Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evaxion A/S - Sponsored ADR (EVAX : NSDQ)
 
 • Company Description   
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.

Number of Employees: 46

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.45 Daily Weekly Monthly
20 Day Moving Average: 115,610 shares
Shares Outstanding: 1.40 (millions)
Market Capitalization: $3.44 (millions)
Beta: 0.12
52 Week High: $17.75
52 Week Low: $1.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -9.93% -13.83%
12 Week 70.14% 38.81%
Year To Date -42.04% -45.06%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Dr. Neergaards Vej 5F
-
Hoersholm,G7 2970
DNK
ph: 45-3131-9753
fax: -
investor@evaxion-biotech.com http://www.evaxion-biotech.com
 
 • General Corporate Information   
Officers
Christian Kanstrup - Chief Executive Officer
Marianne Sogaard - Chairman of the Board of Directors
Jesper Nyegaard Nissen - Chief Operating and Financial Officer
Roberto Prego - Director
Niels Iversen Moller - Director

Peer Information
Evaxion A/S - Sponsored ADR (HLIS)
Evaxion A/S - Sponsored ADR (AZTA)
Evaxion A/S - Sponsored ADR (APYI)
Evaxion A/S - Sponsored ADR (RNVA)
Evaxion A/S - Sponsored ADR (HMSY)
Evaxion A/S - Sponsored ADR (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 29970R303
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 1.40
Most Recent Split Date: 1.00 (0.20:1)
Beta: 0.12
Market Capitalization: $3.44 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.00 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.33
Price/Cash Flow: -
Price / Sales: 1.03
EPS Growth
vs. Year Ago Period: -293.33%
vs. Previous Quarter: -314.29%
Sales Growth
vs. Year Ago Period: 67.12%
vs. Previous Quarter: -95.96%
ROE
06/30/25 - -
03/31/25 - -532.72
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -78.32
12/31/24 - -73.90
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 2.01
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 2.01
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -316.03
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -316.03
Pre-Tax Margin
06/30/25 - -
03/31/25 - -428.27
12/31/24 - -339.56
Book Value
06/30/25 - -
03/31/25 - 7.37
12/31/24 - -1.18
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©